FOXA2 and medullary thyroid gland carcinoma: In this sense it will be also very interesting to explore the expression of CTR in primary and metastatic MTC lesions, as well as in the invasive front vs tumor bulk, in combination with lineage specific markers (Foxa1/Foxa2) and epithelial–mesenchymal transition markers.